STAT

A fertility app bills itself as contraception, raising questions about marketing and efficacy

A fertility tracking app, Dot, is billing itself as contraception — and touting the results of a new efficacy study. But there’s also significant debate over how to measure the…
Source: Indranil Mukherjee/AFP/Getty Images

A new fertility tracking app, Dot, is billing itself as form of contraception — and touting the results of a new efficacy study that shows the app may be up to 99 percent effective as a form of birth control.

With statistics like that, Dot — part of a surge in fertility and contraception apps — would appear to be one of the most effective birth control tools available.

But there’s also significant debate over how to measure the effectiveness of these tools, as well as questions about which apps should be available in the first place. Although Dot is being touted as a form of contraception, it has not yet undergone a Food and

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks